Filed: 11/13/2024ACC: 0000950123-24-011274
📋 What this filing means
NEW LEAF VENTURE PARTNERS, L.L.C. filed this quarterly 13F‑HR report disclosing 10 equity positions with a total reported market value of $97.30M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$97.30M
Total AUM (reported)
10.35M
Total Shares
Allocation by class
COM$96.92M99.6%
SHS$376.1K0.4%
Portfolio Concentration
Top 3$84.01M86.3%
4–10$13.29M13.7%
Top 3 weight
86.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 10.35M
Sole
Full voting authority
10.35M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other10
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings10
Rows:
EDGEWISE THERAPEUTICS INC
DFNDShares1.55M
TypeSH
Market value$41.47M
42.62%
Sole
1.55M
Shared
0.00
None
0.00
ARVINAS INC
DFNDShares1.43M
TypeSH
Market value$35.34M
36.32%
Sole
1.43M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS INC
DFNDShares141K
TypeSH
Market value$7.21M
7.41%
Sole
141K
Shared
0.00
None
0.00
RALLYBIO CORPORATION
DFNDShares3.30M
TypeSH
Market value$3.86M
3.97%
Sole
3.30M
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
DFNDShares150.71K
TypeSH
Market value$2.78M
2.86%
Sole
150.71K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC.
DFNDShares250.76K
TypeSH
Market value$2.71M
2.78%
Sole
250.76K
Shared
0.00
None
0.00
PASSAGE BIO
DFNDShares2.50M
TypeSH
Market value$1.75M
1.80%
Sole
2.50M
Shared
0.00
None
0.00
ALECTOR INC
DFNDShares339.57K
TypeSH
Market value$1.58M
1.63%
Sole
339.57K
Shared
0.00
None
0.00
ITERUM THERAPEUTICS PLC
DFNDShares345.02K
TypeSH
Market value$376.1K
0.39%
Sole
345.02K
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
DFNDShares335K
TypeSH
Market value$224.1K
0.23%
Sole
335K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
EDGEWISE THERAPEUTICS INCDFND | COM | 1.55M | SH | $41.47M 42.62% | 1.55M | 0.00 | 0.00 |
ARVINAS INCDFND | COM | 1.43M | SH | $35.34M 36.32% | 1.43M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INCDFND | COM | 141K | SH | $7.21M 7.41% | 141K | 0.00 | 0.00 |
RALLYBIO CORPORATIONDFND | COM | 3.30M | SH | $3.86M 3.97% | 3.30M | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCDFND | COM | 150.71K | SH | $2.78M 2.86% | 150.71K | 0.00 | 0.00 |
COGENT BIOSCIENCES INC.DFND | COM | 250.76K | SH | $2.71M 2.78% | 250.76K | 0.00 | 0.00 |
PASSAGE BIODFND | COM | 2.50M | SH | $1.75M 1.80% | 2.50M | 0.00 | 0.00 |
ALECTOR INCDFND | COM | 339.57K | SH | $1.58M 1.63% | 339.57K | 0.00 | 0.00 |
ITERUM THERAPEUTICS PLCDFND | SHS | 345.02K | SH | $376.1K 0.39% | 345.02K | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCDFND | COM | 335K | SH | $224.1K 0.23% | 335K | 0.00 | 0.00 |